Human Cerebrospinal Fluid Immunology

  • John L. Trotter
  • Robert S. Rust

Abstract

Historically, antibodies (Abs) were regarded simply as γ-globulins, a class plasma proteins with the least electrophoretic mobility (migrating near t cathode). However, this heterogenous group of proteins migrates as a bro band. Not all γ-globulins are Abs and not all Abs are γ-globulins. Toda all proteins that function as Abs, or that have antigenic determinants in common with Abs, are collectively called immunoglobulins (Igs).

Keywords

Multiple Sclerosis Multiple Sclerosis Patient Optic Neuritis Oligoclonal Band Free Light Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abdou NI (1985). The idiotype-antiidiotype network in human autoimmunity. J Clin Immunol 5:365–369.PubMedGoogle Scholar
  2. 2.
    Allen RC (1980). Rapid isoelectric focusing and detection of nanogram amounts of proteins from body tissues and fluid. Electrophoresis 1:32–37.Google Scholar
  3. 3.
    Ansari KA, Wells K, Vatassery GT (1975). Quantitative estimation of cerebrospinal fluid globulins in multiple sclerosis. Neurology 25:688–692.PubMedGoogle Scholar
  4. 4.
    Arnason BGW, Antel JP, Reder AT (1984). Immuno-regulation in multiple sclerosis. In: Scheinberg L, Raine CS (eds.): Multiple Sclerosis: Experimental and Clinical Aspects. Ann NY Acd Sci 436:133–139.Google Scholar
  5. 5.
    Arnon R, Kelley R, Schumaker VN, Fahey JL (1979). Idiotype antiidiotype complexes in cerebrospinal fluids of multiple sclerosis patients. J Neurol Sci 43:149–156.PubMedGoogle Scholar
  6. 6.
    Baird LG, Tachovsky TG, Sandberg-Wollheim M, Koprowski H, Nisonoff A (1980). Identification of a unique idiotype in cerebrospinal fluid and serum of a patient with multiple sclerosis. J Immun 124:2324–2328.PubMedGoogle Scholar
  7. 7.
    Baumhefner RW, Tourtellotte WW, Potvin AR, Syndulko K, Janes M, Ingram T, Cowan T, Stoks D (1981). Multiple sclerosis central nervous system IgG synthesis: Effect of ‘pulse’ intravenous methylprednisolone succinate. Neurology 31(Suppl 2): 147.Google Scholar
  8. 8.
    Bechhold H (1905). Structurbildung in gallertin. Z Phys Chem 52:185.Google Scholar
  9. 9.
    Berne BH (1974). Differing methodology and equations used in quantitating immunoglobulins by radial immunodiffusion—A comparative evaluation of reported and commercial techniques. Clin Chem 20:61–69.PubMedGoogle Scholar
  10. 10.
    Birnbaum G, Kotilinek L, Schwartz M (1983). Specific reactivity of spinal fluid lymphocytes in multiple sclerosis patients and controls. Neurology 33:139.Google Scholar
  11. 11.
    Bocci L, Goren H, Valenzuela R (1984). Quantitation of intrathecal IgG synthesis in multiple sclerosis: Comparison between Tourtelotte’s and Schuller’s formulas, Link index and cerebrospinal fluid IgG/albumin ratio. Ann Neurol 16:143.Google Scholar
  12. 12.
    Bollengier F, Strosberg AD, Karcher D, Lowenthal A, Rabinovitch-Mahler A (1974). Immunological study of the agent responsible for subacute sclerosing panencephalitis and biochemical characterization of measles antibody in subacute sclerosing panencephalitis. Med Microbiol Immunol 160:173–177.PubMedGoogle Scholar
  13. 13.
    Bollengier F (1986). Free light chains in neurologic disease: First reports. Neurology 36:1010.PubMedGoogle Scholar
  14. 14.
    Booss J, Esiri MM, Tourtellotte WW, Mason DY (1983). Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 62:219–232.PubMedGoogle Scholar
  15. 15.
    Booij J (1959). Agar-agar electrophoresis as an aid in cerebrospinal fluid diagnostics. Folia Psychiat 62:37–43.Google Scholar
  16. 16.
    Bottcher J, Trojaborg W (1982). Follow-up of patients with suspected multiple sclerosis: A clinical and electrophysiological study. J Neurol Neurosurg Psychiat 45:809–814.PubMedGoogle Scholar
  17. 17.
    Bücher T, Matzelt D, Pette D (1952). Papier-elektrophorese von Liquor cerebrospinalis. Klin Wochenschr 30:325–330.PubMedGoogle Scholar
  18. 18.
    Bynke H, Olsson JE, Rosen I (1977). Diagnostic value of visual evoked response, clinical eye examination and CSF analysis in chronic myelopathy. Acta Neurol Scand 56:55–69.PubMedGoogle Scholar
  19. 19.
    Caroscio JT, Kochwa S, Sacks H, Cohen A, Yahr MD (1983). Quantitative CSF IgG mesurements in multiple sclerosis and other neurological diseases. Arch Neurol 40:409–413.PubMedGoogle Scholar
  20. 20.
    Casey BR, Wong ST, Mason AJ, Lee R, Ford HC (1981). The electrophoretic demonstration of unique oligoclonal immunoglobulins in cerebrospinal fluid as a diagnostic test for multiple sclerosis Clin Chim Acta 114:187–194.PubMedGoogle Scholar
  21. 21.
    Cashman N, Martin C, Eizenbaum JF, Degos JD (1982). Monoclonal antibody-defined immuno-regulatory cells in multiple sclerosis cerebrospinal fluid. J Clin Invest 70:387–392.PubMedGoogle Scholar
  22. 22.
    Cawley LP, Minard BJ, Tourtellotte WW, Ma BI, Chelle C (1976). Immunofixation electroYphoretic techniques applied to identification of proteins in serum and cerebrospinal fluid. Clin Chem 22:1262–1268.PubMedGoogle Scholar
  23. 23.
    Cesnak D, Králik M, Pavkovceková O, et al. (1980). Diagnostický význam hodnot IgG V mozgovomiechovom moku pri ochoreniach CNS u detί. Cas Lék Cesk 119(29):796–799.PubMedGoogle Scholar
  24. 24.
    Chou CHJ, Chou FCN, Tourtellotte WW, Kibler RF (1983). Search for a multiple sclerosis-specific brain antigen. Neurology 33:1300–1304.PubMedGoogle Scholar
  25. 25.
    Christianson O, Clausen J, Fog T (1978). Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis. J Neurol 218:237–244.Google Scholar
  26. 26.
    Chu AB, Sever JL, Madden DL, Iivanainen M, Leon M, Wallen W, Brooks BR, Lee YJ, Houff SD (1983). Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases. Ann Neurol 13:434–439.PubMedGoogle Scholar
  27. 27.
    Cohen S, Bannister R (1967). Immunoglobulin synthesis within the central nervous system in disseminated sclerosis. Lancet 1:366–367.PubMedGoogle Scholar
  28. 28.
    Compston DAS, Morgan BP, Oleesky MB, Fifield R, Campbell AK (1986). Cerebrospinal fluid C9 in demyelinating disease. Neurology 36:1503–1506.PubMedGoogle Scholar
  29. 29.
    Confavreux C, Gianazza E, Chazot G, Lasne Y, Arnaud P (1982). Silver stain after isoelecYtric focusing of unconcentrated cerebrospinal fluid: Visualization of total protein and direct immunofixation of immunoglobulin G. Electrophoresis 3:206–210.Google Scholar
  30. 30.
    Connolly JH, Allen IV, Hurivitz LJ, Millar JHD (1967). Measles antibody and antigen in subacute sclerosing panencephalitis. Lancet 1:542–544.PubMedGoogle Scholar
  31. 31.
    Connolly JH, Haire M, Hadden DS (1971). Measles immunoglobulins in subacute sclerosing panencephalitis. Brit Med J 1:23–25.PubMedGoogle Scholar
  32. 32.
    Coyle PK, Johnson C (1983). Optimal detection of oligoclonal bands in CSF by silver stain. Neurology 33:1510.PubMedGoogle Scholar
  33. 33.
    Cutler RWP, Lorenzo AV, Barlow CF (1967). Brain vascular permeability to I125 gamma globulin and leukocytes in allergic encephalomyelitis. J Neuropath Exp Neurol 26:558–571.PubMedGoogle Scholar
  34. 34.
    Cutler RWP, Merler E, Hammerstad JP (1968). Production of antibody by the central nervous system in subacute sclerosing panencephalitis. Neurology 18 (Part 2):129–132.PubMedGoogle Scholar
  35. 35.
    Cutler RWP, Watters GV, Hammerstad JP (1970). The origin and turnover rates of cerebroYspinal fluid albumin and gamma globulin in man. J Neurol Sci 10:259–268.PubMedGoogle Scholar
  36. 36.
    Czlonkowska A, Kodak J, Iwinska B (1986). Subacute sclerosing panencephalitis and progressive multiple sclerosis: T cell subsets in blood and CSF. Neurology 36:992–993.PubMedGoogle Scholar
  37. 37.
    Dalakas MC, Houff SA, Engel WK, Madden DL, Sever JL (1980). CSF “monoclonal” bands in chronic relapsing polyneuropathy. Neurology 30:864–867.PubMedGoogle Scholar
  38. 38.
    Dejaegher L, de Bruyere M, Ketelaer P, Carton H (1983). HLA antigens and progression of multiple sclerosis. Part II. J Neurol 229:167–174.PubMedGoogle Scholar
  39. 39.
    Delmotte P (1972). Comparative results of agar-electrophoresis and isoelectric focusing examination of the gamma-globulins of the cerebrospinal fluid. Acta Neurol Belg 72:226–234.PubMedGoogle Scholar
  40. 40.
    Delpech B, Lichtblau E (1972). Etude quantitative des immunoglobulines G et de l’albumine du liquide céphalo-rachidien. Clin Chim Acta 37:15–23.PubMedGoogle Scholar
  41. 41.
    Duquette P, Charest L (1986). Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients. Neurology 36:727–729.PubMedGoogle Scholar
  42. 42.
    Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, Perla F, Delsedime M, Gusmaroli G, Bergamini L (1986). High-dose intravenous methylprednisolone in the treatYment of multiple sclerosis: Clinical-immunologic correlations. Neurology 36:238–243.PubMedGoogle Scholar
  43. 43.
    Ebers GC, Zabriskie JB, Kunkel HG (1979). Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: A study of idiotypic determinants. Clin Exp Immunol 35:67–75.PubMedGoogle Scholar
  44. 44.
    Ebers GC (1982). A study of CSF idiotypes in multiple sclerosis. Scand J Immunol 16:151–161.PubMedGoogle Scholar
  45. 45.
    Ebers GC (1984). Oligoclonal banding in MS. In: Scheinberg L, Raine CS (eds.): Multiple Sclerosis: Experimental and Clinical Aspects. Ann NY Acad Sci, 436:206–212.Google Scholar
  46. 46.
    Eeg-Olofsson O, Link H, Wigertz A (1981). Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in “normal” subjects from the age of 6 month to 30 years. Acta Paediatr Scand 70:167–170.PubMedGoogle Scholar
  47. 47.
    Eickhoff K, Heipertz R (1978). Determination of immunoglobulin content of CSF based on light chain characteristics. Ann Neurol 3:509–512.PubMedGoogle Scholar
  48. 48.
    Ersmark B, Siden A (1984). Isoelectric focusing of CSF proteins and the future evolution of multiple sclerosis: A clinical follow-up. J Neurol 231:117–121.PubMedGoogle Scholar
  49. 49.
    Esiri MM (1977). Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet 2:478–480.PubMedGoogle Scholar
  50. 50.
    Esiri MM (1980). Multiple sclerosis: A quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. Neuropath Appl Neurobiol 6:9–21.Google Scholar
  51. 51.
    Farrell MA, Kaufmann JCE, Gilbert JJ, Noseworthy JH, Armstrong HA, Ebers GC (1985). Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation. Neurology 35:212–218.PubMedGoogle Scholar
  52. 52.
    Felgenhauer K, Schliep G, Rapic N (1976). Evaluation of the blood—CSF barrier by protein gradients and the humoral immune response within the central nervous system. J Neurol Sci 30:113–128.PubMedGoogle Scholar
  53. 53.
    Felgenhauer K (1982). Differentiation of the humoral immune response in inflammatory diseases of the central nervous system. J Neurol 228:223–237.PubMedGoogle Scholar
  54. 54.
    Flechter S, Arlazoroff A, Goldenberg E (1985). Oligoclonal IgG bands in the CSF of a patient with progressive familial myoclonus. Eur Neurol 24:298–302.PubMedGoogle Scholar
  55. 55.
    Forsberg P, Fryden A (1984). Production of specific antibodies by CSF lymphocytes in patients with Herpes zoster. Lancet 404–405.Google Scholar
  56. 56.
    Forsberg P, Henriksson A, Link H, Ohman, S (1984). Reference values for CSF-IgM, CSF-IgM/S-IgM ratio and IgM index, and its application to patients with multiple sclerosis and aseptic meningoencephalitis. Scan J Clin Lab Invest 44:7–12.Google Scholar
  57. 57.
    Fossard C, Dale G, Latner AL (1970). Separation of proteins of cerebrospinal fluid using gel-electrofocusing followed by electrophoresis. J Clin Path 23:586–589.PubMedGoogle Scholar
  58. 58.
    Franklin EC, Fudenberg HH (1964). Antigenic heterogeneity of human Rh antibodies, rheumatoid factors, and cold agglutinins. Arch Biochem 104:433.PubMedGoogle Scholar
  59. 59.
    Frick E, Scheid-Seydel L (1958). Untersuchungen mit I131-markiertem γ -globulin zur frage der abstammung der liquoreiweissköper. Klin Wochenschr 36:857.PubMedGoogle Scholar
  60. 60.
    Frick E, Scheid-Seydel L (1960). Untersuchungen mit Iı-markierten β-globulin zur frage der abstammung der liquoreiweissköper. Klin Wochenschr 38:1240–1243.PubMedGoogle Scholar
  61. 61.
    Ganrot K, Laurell CB (1974). Mesurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem 20:571–573.PubMedGoogle Scholar
  62. 62.
    George PM Lorier MA, Donaldson I MacG (1983). An evaluation of cerebrospinal fluid oligoclonal banding confirmed by immunofixation on agarose gel. J Neurol Neurosurg Psychiatry 46:500–504.PubMedGoogle Scholar
  63. 63.
    Gerbaut L, Ponsot G, Dulac O, et al. (1981). Profil protéique du liquide céphalo-rachidien chez l’enfant. Determination des limetes de référence. Arch Fr Pediatr 38:3–9.PubMedGoogle Scholar
  64. 64.
    Gerhard W, Taylor A, Wroblewska Z, Sandberg-Wollheim M, Koprowski H (1981). Analysis of a predominant immunoglobulin population in the cerebrospinal fluid of a multiple sclerosis patient by means of an anti-idiotypic hybridoma antibody. Proc Natl Acad Sci USA 78:3225–3229.PubMedGoogle Scholar
  65. 65.
    Gerhard W, Taylor A, Sandberg-Wollheim M, Koprowski H (1985). Longitudinal analysis of three intrathecally produced immunoglobulin subpopulations in an MS patient. J Immunol 134:1555–1560.PubMedGoogle Scholar
  66. 66.
    Gilden D, Tachovsky T (1979). Immunoglobulin elution from multiple sclerosis brain. J Neurosci Method 1:133–142.Google Scholar
  67. 67.
    Glynn P, Gilbert HM, Newcombe J, Cusner ML (1982). Analysis of immunoglobulin G in multiple sclerosis brain: Quantitative and isoelectric focusing studies. Clin Exp Immunol 48:102–110.PubMedGoogle Scholar
  68. 68.
    Grimaldi LME, Roos RP, Nalefski EA, Arnason BGW (1985). Oligoclonal IgA bands in multiple sclerosis and subacute sclerosing panencephalitis. Neurology 35:813.PubMedGoogle Scholar
  69. 69.
    Hall WW, Choppin PW (1981). Measles-virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis. N Engl J Med 304:1152–1155.PubMedGoogle Scholar
  70. 70.
    Harter DH, Yahr MD, Kabat EA (1962). Neurological diseases with elevation of cerebrospinal fluid gamma globulin: a critical review. Trans Am Neurol Assoc 87:210–212.PubMedGoogle Scholar
  71. 71.
    Hartley TF, Merrill DA, Claman HN (1966). Quantitation of immunoglobulins in cerebrospinal fluid. Arch Neurol 15:472–479.PubMedGoogle Scholar
  72. 72.
    Harms D (1974). Comparative quantitation of immunoglobulin G (IgG) in cerebrospinal fluid and serum of children, Eur Neurol 13:54–64.Google Scholar
  73. 73.
    Heidelberger M, Kendal FE (1932). Quantitative studies on the precipitin reaction. The determination of small amounts of a specific polysaccharide. J Exp Med 55:555.PubMedGoogle Scholar
  74. 74.
    Heidelberger M (1939). Quantitative absolute methods in the study of antigen—antibody reaction. Bact Rev 3:49–57.PubMedGoogle Scholar
  75. 75.
    Henriksson A, Kam-Hansen S, Andersson R (1981). Immunoglobulin-producing cells in CSF and blood from patients with multiple sclerosis and other inflammatory neurological diseases enumerated by Protein-A plaque assay. J Neuroimmunol 1:299–309.PubMedGoogle Scholar
  76. 76.
    Henriksson A, Kam-Hansen S, Forsberg P, Grandien M (1986). Cerebrospinal fluid lym-phocytes from patients with multiple sclerosis do not increase immunoglobulin or measles antibody production after stimulation with pokeweed mitogen. J Neuroimmunol 11:15–30.PubMedGoogle Scholar
  77. 77.
    Hershey LA, Trotter JL (1980). The use and abuse of the cerebrospinal fluid IgG profile in the adult: A practical evaluation. Ann Neurol 8:426–434.PubMedGoogle Scholar
  78. 78.
    Hershey LA, Scillin JJ, Trotter JL (1984). Quantitative CSF IgG measurements. Arch Neurol 41:473.PubMedGoogle Scholar
  79. 79.
    Hirohata S, Inoue T, Yamada A, Hirose S, Miyamoto T (1984). Quantitation of IgG, IgA and IgM in the cerebrospinal fluid by a solid-phase enzyme-immunoassay. J Neurol Sci 63:101–110.PubMedGoogle Scholar
  80. 80.
    Hische EAH, Vanderhelm HJ, VanWalbeek HK (1982). The cerebrospinal fluid immunoYglobulin G index as a diagnostic aid in multiple sclerosis—a Bayesian approach. Clin Chem 28:3–54.Google Scholar
  81. 81.
    Hommes OR, Lamers KJB, van Geel W (1984). Intrathecal IgG synthesis and IgG index after intensive and chronic immunosuppressive treatment of multiple sclerosis. In: Scheinberg L, Paine CS (eds.): Multiple Sclerosis: Experimental and Clinical Aspects. Ann NY Acad Sci. 436:410–417.Google Scholar
  82. 82.
    Hosein ZZ, Johnson KP (1981). Isoelectric focusing of cerebrospinal fluid proteins in the diagnosis of multiple sclerosis. Neurology 31:70–76.PubMedGoogle Scholar
  83. 83.
    Hrazdirová V, Hrazdira CL, Polcáková M (1982). Immunoglobuliny V mozkomisnim moku deti trpicich epilepsil. Cesk Neurol Neurochir 45(4):224–228.PubMedGoogle Scholar
  84. 84.
    Huntley AC, Fletcher MP, Ikeda RM, Gershwin ME (1977). Shared antigenic determinants between rabbit antihuman thymocyte sera: relationship to the lymphocytotoxic antibodies of systemic lupus. Clin Immunol Immunopath 7:269–280.Google Scholar
  85. 85.
    Ivanainen MV, Wallen, W, Leon ME, Keski-Oja J, Calabrese VP, Krasny MA, Waybright EA, Selhorst JB, Harbison JW, Madden DL, Sever JL (1981). Micromethod for detection of oligoclonal IgG in unconcentrated CSF by Polyacrylamide gel electrophoresis. Arch Neurol 38:427.Google Scholar
  86. 86.
    Iwashita H, Grunwald V, Bauer H (1974). Double ring formation in single radial immunodiffusion for kappa chains in multiple sclerosis cerebrospinal fluid. J Neurol 207:45–52.PubMedGoogle Scholar
  87. 87.
    Jamieson DG, Mehta PD, Lavi E (1986). Oligoclonal immunoglobulin bands in cerebrospinal fluid of a patients with lymphocytic choriomeningitis. Ann Neurol 19:386–388.PubMedGoogle Scholar
  88. 88.
    Johnson KP, Nelson BJ (1977). Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid. Ann Neurol 2:425–431.PubMedGoogle Scholar
  89. 89.
    Johnson KP, Likosky H, Nelson BJ, Fein C (1980). Comprehensive viral immunology of multiple sclerosis I: Clinical, epidemiological, and CSF studies. Arch Neurol 37:537–541.PubMedGoogle Scholar
  90. 90.
    Kabat EA, Moore DH, Landow H (1942). An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J Clin Invest 21:571–577.PubMedGoogle Scholar
  91. 91.
    Kabat EA, Hanger FM, Moore DH, Landow H (1943). The relation of cephalin flocculation and colloidal gold reactions to the serum proteins. J Clin Invest 22:563–568.PubMedGoogle Scholar
  92. 92.
    Kabat EA, Glusman M, Knaub V (1948). Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Am J Med 4:653–662.PubMedGoogle Scholar
  93. 93.
    Kabat EA, Freedman DA, Murray JP, Knaub V (1950). A study of the crystalline albumin, gamma globulin and total protein on the cerebrospinal fluid of one hundred cases of multiple sclerosis and in other diseases. Am J Med Sci 219:55–64.PubMedGoogle Scholar
  94. 94.
    Karitzky D (1975). Die quantitative bestimmung einzelner liquorproteine in der diagnostik entzündlicher ZNS-erkrankungen im kindesalter. Eur J Pediatr 121:51–57.PubMedGoogle Scholar
  95. 95.
    Kasai N, Pachner AR, Yu PK (1986). Anti-glycolipid antibodies and their immune complexes in multiple sclerosis. J Neurol Sci 75:33–42.PubMedGoogle Scholar
  96. 96.
    Keir G, Walker RWH, Thompson EJ (1982). Oligoclonal immunoglobulin M in cerebrospinal fluid from multiple sclerosis patients. J Neurol Sci 57:281–285.PubMedGoogle Scholar
  97. 97.
    Kerenyi L, Hedgedus K, Palffy G (1975). Characteristic gamma globulin subfractions of native CSF in multiple sclerosis. Brain Res 87:123–125.Google Scholar
  98. 98.
    Kiessling WR, Hall WW, Yung LL, Meulen VT (1977). Measles-virus-specific immuno-globulin-M responses in subacute sclerosing panencephalitis. Lancet 1:324–327.PubMedGoogle Scholar
  99. 99.
    Kinnman J, Link H (1984). Intrathecal production of oligoclonal IgM and IgG in the CNS. Acta Neurol Scand 69:97–106.PubMedGoogle Scholar
  100. 100.
    Kolar OJ (1977). Light chains in cerebrospinal fluid in multiple sclerosis. Lancet 2:1030–1031.PubMedGoogle Scholar
  101. 101.
    Kolar OJ, Rice PH, Jones FH, Defalque RJ, Kincaid J (1980). Cerebrospinal fluid immuno-electrophoresis in multiple sclerosis. J Neurol Sci 47:221–230.PubMedGoogle Scholar
  102. 102.
    Kostulas VK, Link H (1982). Agarose isoelectric focusing of unconcentrated CSF and radio-immunofixation for detection of oligoclonal bands in patients with multiple sclerosis and other neurological diseases. J Neurol Sci 54:117–127.PubMedGoogle Scholar
  103. 103.
    Lane JR, Bowles KJ, Normansell DE (1984). Detection of oligoclonal IgG bands in cerebrospinal fluid by isoelectric focusing on thin layer agarose gels. Ann Clin Lab Sci 14:146.PubMedGoogle Scholar
  104. 104.
    Lange C (1912).Üsber die ausflockung von goldsol durch liquor cerebrospinalis. Berl Klin Wochenschr 49:897–901.Google Scholar
  105. 105.
    Lange C (1946). Interpretation of findings in the cerebrospinal fluid. II. The technic and systematic intrepretation of the albumin—globulin ratio in cerebrospinal fluid. J Clin Med 31:552.Google Scholar
  106. 106.
    Lasne Y, Benzerara O, Chazot G, Creyssel R (1981). A sensitive method for characterization of oligoclonal immunoglobulins in unconcentrated cerebrospinal fluid. J Neurochem 36: 1872–1874.PubMedGoogle Scholar
  107. 107.
    Laterre EC, Callewaert A, Heremans JF, Sfaello Z (1970). Electrophoretic morphology of gamma globulin in the cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology 20:982–990.PubMedGoogle Scholar
  108. 108.
    Laurell CB (1966). Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45–55.PubMedGoogle Scholar
  109. 109.
    Laurenzi MA, Link H (1979). Characterization of the mobility on isoelectric focusing of individual proteins in CSF and serum by immunofixation. J Neurol Neurosurg Psyehiat 42:368–372.Google Scholar
  110. 110.
    Laurenzi MA, Mavra M, Kam-Hansen S, Link H (1980). Oligoclonal IgG and free light chains in multiple sclerosis demonstrated by thin-layer Polyacrylamide gel isoelectric focusYing and immunofixation. Ann Neurol 8:241–249.PubMedGoogle Scholar
  111. 111.
    Lefvert AK, Link H (1985). IgG production within the central nervous system: A critical review of proposed formulae. Ann Neurol 17:13–20.PubMedGoogle Scholar
  112. 112.
    Levin AS, Fudenberg HH, Petz LD, Sharp GC (1972). IgG levels in cerebrospinal fluid of patients with central nervous system manifestations of systemic lupus erythematosus. Clin Immunol Immunopath 1:1–5.Google Scholar
  113. 113.
    Liappis N, Jäkel A (1976). Normalbereich der mittels radialer immunodiffusion bestimmten albumin- un IgG-konzentratino im liquor cerebrospinalis von kindern. Klin Pädiatr 188: 267–270.PubMedGoogle Scholar
  114. 114.
    Link H (1967). Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid: chemical and immunological characterisation with special reference to multiple sclerosis. Acta Neurol Scand (Suppl) 28:1–136.Google Scholar
  115. 115.
    Link H, Zettervall O (1970). Multiple sclerosis: disturbed kappa—lambda chain ratio of immunoglobulin G in cerebrospinal fluid. Clin Exp Immunol 6:435–438.PubMedGoogle Scholar
  116. 116.
    Link H, Muller R (1971). Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol 25:326–344.PubMedGoogle Scholar
  117. 117.
    Link H (1973). Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin Chim Acta 6:383–389.Google Scholar
  118. 118.
    Link H (1973). Immunoglobulin abnormalities in the Guillain-Barré syndrome. J Neurol Sci 18:11–23.PubMedGoogle Scholar
  119. 119.
    Link H, Panelius M, Salon AA (1973). Immunoglobulins and measles antibodies in subacute sclerosing panencephalitis. Arch Neurol 28:23–30.PubMedGoogle Scholar
  120. 120.
    Link H (1975). Demonstration of oligoclonal immunoglobulin G in Gullain-Barré syndrome. Acta Neurol Scand 52:111–120.PubMedGoogle Scholar
  121. 121.
    Link H, Norrby E, Olsson JE (1976). Immunoglobulin abnormalities and measles antibody response in chronic myelopathy. Arch Neurol 33:26–32.PubMedGoogle Scholar
  122. 122.
    Link H, Tibbling G (1977). Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 37:397–401.PubMedGoogle Scholar
  123. 123.
    Link H, Laurenzi MA (1979). Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immuno-fixation. Ann Neurol 6:107–110.PubMedGoogle Scholar
  124. 124.
    Link H, Wahrens B, Norrby E (1979). Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpes virus serology in patients with Guillain-Barr, syndrome. J Clin Microbiol 9:305–315.PubMedGoogle Scholar
  125. 125.
    Link H, Kostulas V (1983). Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients. Clin Chem 29:810–815.PubMedGoogle Scholar
  126. 126.
    Link H, Stendahl-Brodin L (1983). Optic neuritis and multiple sclerosis. N Engl J Med 308:1294–1295.PubMedGoogle Scholar
  127. 127.
    Lisak RP, Zweiman B, Whitaker JN (1981). Spinal fluid basic protein immuno-reactive material and spinal fluid lymphocyte reactivity to basic protein. Neurology 31:180–182.PubMedGoogle Scholar
  128. 128.
    Lisak RP, Zweiman B, Burns JB, Rostami A, Silberberg DH (1984). Immune responses to myelin antigens in multiple sclerosis. In: Scheinberg L, Raine CS (eds.): Multiple Sclerosis: Experimental and Clinical Aspects. Ann NY Acad Sci 436:221–230.Google Scholar
  129. 129.
    Liskiewicz W (1982). The nature of oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis. Clin Chim Acta 123:145–152.PubMedGoogle Scholar
  130. 130.
    Livrea P, Trojano M, Simone IL, Zimatore CB, Lamontanara G, Leanate R (1981). Intra-thecal IgG synthesis in multiple sclerosis: comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgG. J Neurol 224:159–169.PubMedGoogle Scholar
  131. 131.
    Lolli F, Fredrikson S, Kam-Hansen S, Linke H (1987). Increased reactivity to HTLV-I in inflammatory nervous system diseases. Ann Neurol 22:67–71.PubMedGoogle Scholar
  132. 132.
    Lowenthal A, Vansande M, Karcher D (1960). The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF G-globulins. J Neurochem 6:51–60.Google Scholar
  133. 133.
    Lowenthal A (1964). Agar Gel Electrophoresis in Neurology. Amsterdam, New York: Elsevier.Google Scholar
  134. 134.
    Lumsden CE (1965). The clinical immunology of multiple sclerosis. In: McAlpine D, Lumsden CE, Acheson CE (eds.): Multiple Sclerosis: A Reappraisal. Baltimore: Williams and Wilkins, pp. 345–380.Google Scholar
  135. 135.
    Luster MI, Armen RC, Hallum JV, Leslie GA (1976). Measles virus-specific IgD antibodies in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci USA 73:1297.PubMedGoogle Scholar
  136. 136.
    Ma BI, Tourtellotte WW, Brandes DW, Sever JL (1976). Quantitation of measles and brain specific IgG in subacute sclerosing panencephalitis cerebrospinal fluid. Fed Proc 35:391.Google Scholar
  137. 137.
    Mancini G, Carbonara AO, Heremans JF (1965). Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 3:235.Google Scholar
  138. 138.
    Massaro AR (1978). Modifications of the cerebrospinal fluid IgG concentrations in patients with multiple sclerosis treated with intrathecal steroids. J Neurol 219:221–226.PubMedGoogle Scholar
  139. 139.
    Mattson DH, Roos RP, Arnason BGW (1980). Immunoperoxidase staining of cerebrospinal fluid IgG in isoelectric focusing gels: A sensitive new technique. J Neurosci Methods 3:67–76.PubMedGoogle Scholar
  140. 140.
    Mattson DH, Roos RP, Arnason BGW (1980) Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature 287:335–337.PubMedGoogle Scholar
  141. 141.
    Mattson DH, Roos RP, Arnason BGW (1981). Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol 9:34–41.PubMedGoogle Scholar
  142. 142.
    Mattson DH, Roos RP, Arnason BGW (1982). Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis brains. J Neuroimmunol 2:261–276.PubMedGoogle Scholar
  143. 143.
    Mazzarello P, Poloni M, Ceroni M, Scelsi R (1985). Is progressive multifocal leukoence-phalopathy associated with intrathecal IgG synthesis? J Neuroimmunol 10:167–172.PubMedGoogle Scholar
  144. 144.
    Mehta PD, Kane A, Thormar H (1976). Measles specific IgG in subacute sclerosing panencephalitis (SSPE). Fed Proc 35:759.Google Scholar
  145. 145.
    Mehta PD, Kane A, Thormar H (1977). Quantitation of measles virus specific immunoglobulins in serum, CSF and brain extract from patients with subacute sclerosing panenYcephalitis. J Immunol 118:2254–2261.PubMedGoogle Scholar
  146. 146.
    Mehta PD, Frisch S, Thormar H, Tourtellotte WW, Wisniewski HM (1981). Bound antibody in multiple sclerosis brains. J Neurol Sci 49:91–98.PubMedGoogle Scholar
  147. 147.
    Mehta PD, Patrick BA, Wisniewski HM (1981). Isoelectric focusing and immunofixation of cerebrospinal fluid and serum in multiple sclerosis. J Clin Lab Immunol 6:17–22.PubMedGoogle Scholar
  148. 148.
    Mehta PD, Mehta SP, Patrick BA (1982) Identification of light chain type bands in CSF and serum oligoclonal IgG from patients with multiple sclerosis. J Neuroimmunol 2:119–129.PubMedGoogle Scholar
  149. 149.
    Mehta PD, Miller JA, Tourtellotte WW (1982). Oligoclonal IgG bands in plaques from multiple sclerosis brains. Neurology 32:3723–76.Google Scholar
  150. 150.
    Mehta PD, Patrick BA (1983). Detection of oligoclonal bands in unconcentrated CSF: Isoelectric focusing and silver staining. Neurology 33:1365–1368.PubMedGoogle Scholar
  151. 151.
    Merril CR, Goldman D, Sedman SA, Ebert MA (1981). Ultrasensitive stain for proteins in Polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science 211: 1437–1438.PubMedGoogle Scholar
  152. 152.
    Merrill D, Hartley TF, Claman HN (1966). Electroimmunodiffusion (EID): A simple, rapid method for quantitation of immunoglobulins in dilute biological fluids. J Lab Clin Med 69:151–159.Google Scholar
  153. 153.
    Merrill JE, Myers LW, Ellison GW (1984). Cytotoxic cells in peripheral blood and cerebrospinal fluid of multiple patients. In: Scheinberg L, Raine CS (eds.): Multiple Sclerosis: Experimental and Clinical Aspects. Ann NY Acad Sci 436:192–205.Google Scholar
  154. 154.
    Miller JR, Burke AM, Bever CT (1983). Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases. Ann Neurol 13:53–58.PubMedGoogle Scholar
  155. 155.
    Mingioli ES, Strober W, Tourtellotte WW, Whitaker JN, McFarlin DE (1978). Quantitation of IgG, IgA, and IgM in the CSF by radioimmunoassay. Neurology 28:991–995.PubMedGoogle Scholar
  156. 156.
    Moench TR, Griffin DE (1984). Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges and brain during acute viral meningoencephalitis. J Exp Med 159:77–88.PubMedGoogle Scholar
  157. 157.
    Moulin D, Paty DW, Ebers GC (1983). The predictive value of cerebrospinal fluid electrophoresis in ‘possible’ multiple sclerosis. Brain 106:809–816.PubMedGoogle Scholar
  158. 158.
    Naess A, Nyland H (1978). Multiple sclerosis—T lymphocytes in cerebrospinal fluid and blood. Eur Neurol 17:6166.Google Scholar
  159. 159.
    Nagelkerken LM, Aalberse RC, Van Walbreek HK, Out TA (1980). Preparation of anti-sera directed against the idiotype(s) of immunoglobulin G from the cerebrospinal fluid of patients with multiple sclerosis. J Immunol 125:384–389.PubMedGoogle Scholar
  160. 160.
    Nagelkerken LM, Van Zoonen-van EM, Van Walbeek HK, Aalberse RC, Out A (1982). Analysis of cerebrospinal fluid and serum of patients with multiple sclerosis by means of anti-idiotypic antisera. J Immunol 128:1102–1106.PubMedGoogle Scholar
  161. 161.
    Nagelkerken LM, Out TA (1983). In vitro stimulated peripheral blood lymphocytes from multiple sclerosis patients produce idiotypes of oligoclonal CSF IgG. J Immunol 131: 2328–2331.PubMedGoogle Scholar
  162. 162.
    Nerenberg ST, Prasad R (1975). Radioimmunoassays for Ig classes G, A, M, D and E in spinal fluids: Normal values of different age groups. J Lab Clin Med 86:887–898.PubMedGoogle Scholar
  163. 163.
    Neuwelt E, Doherty D (1977). Toxicity kinetics and clinical potential of subarachnoid lymphocyte infusions. J Neurosurg 47:205–217.PubMedGoogle Scholar
  164. 164.
    Newcombe J, Glynn P, Cuzner ML (1982). Analysis by transfer electrophoresis of reactivity of IgG with brain proteins in multiple sclerosis. J Neurochem 39:1192–1194.PubMedGoogle Scholar
  165. 165.
    Nikoskelainen E, Irjala K, Salmi A (1975). Cerebrospinal fluid findings in patients with optic neuritis. Acta Ophthalmol 53:105–119.Google Scholar
  166. 166.
    Nikoskelainen E, Frey H, Salmi A (1981). Prognosis of optic neuritis with special reference to cerebrospinal fluid immunoglobulins and measles virus antibodies. Ann Neurol 9:545–550.PubMedGoogle Scholar
  167. 167.
    Nordal HJ, Vandvik B, Natvig JB (1977). Idiotype of measles virus nucleocapsid-specific IgG 03BA antibody in serum and cerebrospinal fluid in subacute sclerosing panencephalitis. Scand J Immunol 6:1351–1356.Google Scholar
  168. 168.
    Nordal HJ Vandvik B, Norrby E (1978). Multiple sclerosis: Local synthesis of electropho-retically restricted measles, rubella, mumps and Herpes simplex virus antibodies in the central nervous system. Scand J Immunol 7:473–479.PubMedGoogle Scholar
  169. 169.
    Noronha ABC, Richman DP, Arnason BGW (1980). Detection of in vivo stimulated cerebrospinal fluid lymphocytes by flow cytometry in patients with multiple sclerosis. N Engl J Med 303:713–717.PubMedGoogle Scholar
  170. 170.
    Noronha A, Jensen M, Bright K, Thalji Z, Tarof D (1986). Multiple sclerosis: Cerebrospinal fluid T-cell lines show natural effector cell activity. Ann Neurol 20:168.Google Scholar
  171. 171.
    Norrby E, Vandvik B (1975). Relationship between measles virus-specific antibody activities and oligoclonal IgG in the central nervous system of patients with subacute sclerosing panencephalitis and multiple sclerosis. Med Microbiol Immunol 162:63–72.PubMedGoogle Scholar
  172. 172.
    Oakley BR, Kirsch DR, Morris NR (1980). A simplified ultransensitive silver stain for detecting proteins in Polyacrylamide gels. Anal Biochem 105:361–363.PubMedGoogle Scholar
  173. 173.
    Oehmichen M, Genicic M (1975). Experimental studies on kinetics and functions of mononuclear phagocytes of the central nervous system. Acta Neuropath (Suppl 6):285–290.Google Scholar
  174. 174.
    Oehmichen M, Gruninger H (1976). Cytokinetic studies on the origin of cells of the cerebrospinal fluid. J Neurol 22:165–176.Google Scholar
  175. 175.
    Oger JJF, Antel JP, Mariotti S, Arnason BGW (1980). In vitro-IgG secretion by lymphocytes of multiple sclerosis patients and controls in response to pokeweed mitogen stimulation. Neurology 30:484.Google Scholar
  176. 176.
    Oldendorf WH (1967). What is cerebrospinal fluid? Bull Los Angeles Neurol Soc 32:169–180.Google Scholar
  177. 177.
    Olsson JE, Link H (1973). Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbation and remissions. Arch Neurol 28:392–399.PubMedGoogle Scholar
  178. 178.
    Olsson JE, Link H, M_ller R (1976). Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: Disability, duration and age of onset. J Neurol Sci 27: 233–245.PubMedGoogle Scholar
  179. 179.
    Olsson JE, Nilsson K (1979). Gamma globulins of CSF and serum in multiple sclerosis: Isoelectric focusing on Polyacrylamide gel and agar gel electrophoresis. Neurology 29: 1382–1391.Google Scholar
  180. 180.
    Ouchterlony O (1949). Antigen-antibody reactions in gels. Acta Pathol Microbiol Scand 26:507.PubMedGoogle Scholar
  181. 181.
    Oxelius V-A, Rorsman H, Laurell AB (1969). Immunoglobulins of cerebrospinal fluid in syphilis. Br J Verier Dis 45:121.Google Scholar
  182. 182.
    Paty DW, Blume WT, Brown WF, Jaatoul N, Kertesz A, McInnis W (1979). Chronic progressive myelopathy: Investigation with CSF electrophoresis evoked potentials and CAT scan. Ann Neurol 6:419–424.PubMedGoogle Scholar
  183. 183.
    Payne FE, Baublis JV, Itabashi HH (1969). Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N Engl J Med 281:585–589.PubMedGoogle Scholar
  184. 184.
    Perini JM, Lebas J, Roussel P, Biserte G (1979). Evidence for heterogeneous or incomplete immunoglobulins in oligoclonal CSF studied by electroimmunofixation. Clin Chim Acta 96:205–214.PubMedGoogle Scholar
  185. 185.
    Perry JJ, Bray PF, Hackett TM (1974), Comparison of electroimmunodiffusion and radial immunodiffusion for measurement of IgG in the laboratory diagnosis of multiple sclerosis. Clin Chem 20:1441–1443.PubMedGoogle Scholar
  186. 186.
    Peter A, Lowenthal A, Juvancz I (1974). Changes of y globulins in serum and cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Neurol 207:85–92.PubMedGoogle Scholar
  187. 187.
    Peter JB, Tourtellotte WW (1986). Modest serum contamination of cerebrospinal fluid (CSF) invalidates the calculation of intra-blood—brain barrier (BBB) IgG synthesis and intra-BBB albumin formation but not unique CSF oligoclonal IgG bands. Ann Neurol 20:167.Google Scholar
  188. 188.
    Peterslung NA, Pedersen B (1982). Liquor: serum quotients of IgG and albumin in patients with meningism, meningitis and multiple sclerosis. Acta Neurol Scand 66:25–33.Google Scholar
  189. 189.
    Porter KG, Sinnamon DG, Gillies RR (1977). Cryptococcus neoformans-specific oligoYclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis. Lancet 1:1262.PubMedGoogle Scholar
  190. 190.
    Poser M (1984). Taxonomy and diagnostic parameters in multiple sclerosis. In: Scheinberg L, Raine CS (eds.): Multiple Sclerosis: Experimental and Clinical Aspects. Ann NY Acad Sci 436:233–236.Google Scholar
  191. 191.
    Poser M, Paty DW, Scheinberg L, McDonald I, Davis A, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983). New diagnostic criteria for multiple scleroYsis: Guidelines for research protocols. Ann Neurol 13:227–231.PubMedGoogle Scholar
  192. 192.
    Prineas JW, Wright RG (1978). Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 38:409–421.PubMedGoogle Scholar
  193. 193.
    Prineas JW (1979). Multiple sclerosis: Presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203:1123–1125.PubMedGoogle Scholar
  194. 194.
    Raine CS (1984). Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50:608–635.PubMedGoogle Scholar
  195. 195.
    Riberi M, Bernard D, Depieds R (1975). Evidence for the presence of λ chain dimers in cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis. Clin Exp Immunol 19:45–53.PubMedGoogle Scholar
  196. 196.
    Ricciomi H, Masson PL, Heremans JF (1972). Evaluation of the Technicon automated specific protein analytical system. In: Hamm JD (ed.): Automated Immuno-Precipitin Reactions. New Methods, Techniques and Evaluations. Tarrytown, NY: Technicon Instruments Corp., p. 53.Google Scholar
  197. 197.
    Richert JR, Rose JW, Xu Xian-Hau, Greenstein JI, McFarland HF, McFarlin DE (1984). Characterization of cerebrospinal fluid lymphocytes in multiple sclerosis. In: Scheinberg L, Raine CS (eds.): Multiple Sclerosis: Experimental and Clinical Aspects. Ann NY Acad Sci 436:151–162.Google Scholar
  198. 198.
    Rieber H (1980). Evaluation of IgG synthesis in the central nervous system. In: Bauer HJ, Poser S, Ritter G (eds.): Progress in Multiple Sclerosis Research. Berlin: Springer-Verlag, pp. 154–156.Google Scholar
  199. 199.
    Rocchelli B, Poloni M, Mazzarello P, Delodovici M (1981). Identification of the κ and λ light chains within the CSF immunoglobulin region in multiple sclerosis and subacute sclerosing panencephalitis by immunofixation after isoelectric focusing. J Neurol 226:169–179.PubMedGoogle Scholar
  200. 200.
    Rocchelli B, Poloni M, Mazzarello P, Delodovici M (1983). Clinical and CSF findings in multiple sclerosis patients with or without IgG oligoclonal bands on isoelectric focusing examination of CSF and serum proteins. Eur Neurol 22:35–42.PubMedGoogle Scholar
  201. 201.
    Rostrom B, Link H (1981). Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease. Neurology 31:590–596.PubMedGoogle Scholar
  202. 202.
    Rostrom B, Link H, Norrby E (1981). Antibodies in oligoclonal immunoglobulins in CSF from patients with acute cerebrovascular disease. Acta Neurol Scand 64:225–240.PubMedGoogle Scholar
  203. 203.
    Rostrom B, Link H, Laurenzi MA, Kam-Hansen S, Norrby E, Wahren B (1981). Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis. Ann Neurol 9:569–574.PubMedGoogle Scholar
  204. 204.
    Rostrom B (1982). Antibodies against viruses and structural brain components in oligoclonal IgG obtained from multiple sclerosis brain. J Neurol 226:255–263.PubMedGoogle Scholar
  205. 205.
    Rudick RA, Bidlack JM (1984). Specificity of CSF immunoglobulin (IgG) in multiple sclerosis: Assessment by Ig stain of “blots” of protein separated by SDS-PAGE. Neurology 34:77.Google Scholar
  206. 206.
    Rudick RA, Bidlack JM, Knutson DW (1985). Multiple sclerosis cerebrospinal fluid immune complexes that bind C1q. Arch Neurol 42:856–858.PubMedGoogle Scholar
  207. 207.
    Rudick RA, Peter DR, Bidlack JM, Knutson DW (1985). Multiple sclerosis: Free light chains in cerebrospinal fluid. Neurology 35:1443–1449.PubMedGoogle Scholar
  208. 208.
    Rudick RA, Dunn MG (1986). Cerebrospinal fluid kappa chains in multiple sclerosis: Correlation with clinical and laboratory features. Ann Neurol 20:123.Google Scholar
  209. 209.
    Rudick RA, Jacobs L, Kinkel PR, Kinkel WR (1986). Isolated idiopathic optic neuritis. Analysis of free H-light chains in cerebrospinal fluid and correlation with nuclear magnetic resonance findings. Arch Neurol 43:456–458.PubMedGoogle Scholar
  210. 210.
    Rudick RA, Pallant A, Bidlack JM, Herndon RM (1986). Free kappa light chains in multiple sclerosis spinal fluid. Ann Neurol 20:63–69.PubMedGoogle Scholar
  211. 211.
    Rumbach L, Tongio MM, Warter JM, Marescaux C, Mayer S, Rohmer F (1982). Lympho-cytotoxic and monocytotoxic antibodies in the serum and cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 3:263–273.PubMedGoogle Scholar
  212. 212.
    Rust RS, Dodson WE, Trotter JL (1986). Cerebrospinal fluid immunoglobulins in childYhood: Normal values. Ann Neurol 20:407.Google Scholar
  213. 213.
    Rust RS, Dodson WE, Trotter JL (1988). Cerebrospinal fluid IgG in childhood: The establishment of reference values. Ann Neurol 23:406–410.PubMedGoogle Scholar
  214. 214.
    Salier JP, Goust JM, Pandey JP, Fudenberg HH (1981). Preferential synthesis of the G1m (1) allotype of IgG1 in the central nervous system of multiple sclerosis patients. Science 213:1400–1402.PubMedGoogle Scholar
  215. 215.
    Salier JP, Glynn P, Goust JM, Cuzner L (1983). Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain. Clin Exp Immunol 54:634–640.PubMedGoogle Scholar
  216. 216.
    Salier JP, Goust JM, Link H, Pandey JP, Daveau M, Fudenberg HH (1983). Latent immunoglobulin G (Gm) allotypes: Occurrence in the cerebrospinal fluid in some neuropathological states. J Immunogenet 10:3113–18.Google Scholar
  217. 217.
    Salmi A, Viljanen M, Reunanen M (1981). Intrathecal synthesis of antibodies to diphtheria and tetanus toxoids in multiple sclerosis patients. J Neuroimmunol 1:33–341.Google Scholar
  218. 218.
    Sandberg M, Bynke H (1973). Cerebrospinal fluid in 25 cases of optic neuritis. Acta Neurol Scand 49:443–452.PubMedGoogle Scholar
  219. 219.
    Sandberg-Wollheim M (1975). Optic neuritis: Studies on the cerebrospinal fluid in relation to clinical course in 61 patients. Acta Neurol Scand 52:167–178.PubMedGoogle Scholar
  220. 220.
    Sandberg-Wollheim M, Baird LG, Schanfield MS, Knoppers MH, Youker K, Tachnovsky TG (1984). Association of CSF IgG concentration and immunoglobulin allotype in multiple sclerosis and optic neuritis. Clin Immunopath 31:212–221.Google Scholar
  221. 221.
    Sanders EACM, Reulen JPH, Van der Velde EA, Hogenhuis LAH (1986). The diagnosis of multiple sclerosis: contribution of non-clinical tests. J Neurol Sci 72:273–285.PubMedGoogle Scholar
  222. 222.
    Sanders ME, Koski CL, Robbins D, Shin ML, Frank MM, Joiner KA (1986). Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. J Immunol 136: 4456–4459.PubMedGoogle Scholar
  223. 223.
    Schinko H, Tschabitscher H (1959). Der γ-Quotient als differentialdiagnostisches Kriterium zwischen multipler Sklerose und besonderer Berücksichtigung der Krankheitsdauer. Wien Klin Wochenschr 71:417–422.Google Scholar
  224. 224.
    Schmidt R, Rieder HP, Wüthrich RP (1977). The course of multiple sclerosis cases with extremely high γ-globulin values in the cerebrospinal fluid. Eur Neurol 15:241–248.PubMedGoogle Scholar
  225. 225.
    Schneck SA, Claman HN (1969). CSF immunoglobulins in multiple sclerosis and other neurologic diseases. Measurement by electroimmunodiffusion. Arch Neurol 20:132–139.PubMedGoogle Scholar
  226. 226.
    Schuller E, Sagar HJ (1981). Local synthesis of CSF immunoglobulins. J Neurol Sci 51: 3613–70.Google Scholar
  227. 227.
    Schuller E, Sager HJ (1982). Central nervous system IgG synthesis in multiple sclerosis. Acta Neurol Scand 67:765–771.Google Scholar
  228. 228.
    Schuller E, Sagar HJ (1986). Measuring IgG production within the central nervous system. Ann Neurol 20:373–374.PubMedGoogle Scholar
  229. 229.
    Schwalbe G (1869). Die arachnoidalraum, ein lymphraum und sein Zusammenhang mit dem perichoriordalraum. Zentralbl Med Wiss 7:465–467.Google Scholar
  230. 230.
    Schwarze E (1973) Cytomorphologischer vergleich der kleinen und “grossen Rundzelle” des liquor cerebrospinalis mit lymphozyten des peripheren blutes. Verla Dtsch Ges Pathol 57:262–268.Google Scholar
  231. 231.
    Shorr J, Rostrom B, Link H (1981). Antibodies to viral and nonviral antigens in subacute sclerosing panencephalitis and multiple sclerosis demonstrated by thin-layer Polyacrylamide gel isoelectric focusing, antigen immunofixation and autoradiography. J Neurol Sci 49: 99–108.PubMedGoogle Scholar
  232. 232.
    Siemes H, Siegert M, Hanefeld F (1981). Occurrence of oligoclonal gammaglobulin in the CSF of children with prolonged and chronic CNS-infections. Acta Paediatr Scand 70:91–99.PubMedGoogle Scholar
  233. 233.
    Siemes H, Siegert M, Hanefeld F, Kolmel HW, Paul F (1977). Oligoclonal gamma-globulin banding of cerebrospinal fluid in patients with subacute sclerosing panencephalitis. J Neurol Sci 32:395–409.PubMedGoogle Scholar
  234. 234.
    Sindic CJM, Cambiaso CL, Masson PL, Laterre EC (1980). The elution of IgG from subacute sclerosing panencephalitis and multiple sclerosis brains. Clin Exp Immunol 41:8–12.PubMedGoogle Scholar
  235. 235.
    Sindic CJM, Cambiaso CL, Depre A, Laterre EC, Masson PL (1982). The concentration of IgM in the cerebrospinal fluid of neurological patients. J Neurol Sci 55:339–350.PubMedGoogle Scholar
  236. 236.
    Sindic CJM, Magnusson CGM, Laterre EC, Masson PL (1984). IgE in the cerebrospinal fluid. J Neuroimmunol 6:319–324.PubMedGoogle Scholar
  237. 237.
    Skoldenberg B, Carlstrom A, Forsgren M, Norrby E (1976). Transient appearance of oligoclonal immunoglobulins and measles virus antibodies in the cerebrospinal fluid in a case of acute measles encephalitis. Clin Exp Immunol 23:451–455.PubMedGoogle Scholar
  238. 238.
    Smith H, Bannister B, O’Shea MS (1973). Cerebrospinal-fluid immunoglobulins in menYingitis. Lancet 2:591–593.PubMedGoogle Scholar
  239. 239.
    Soiling K (1981). Free light chains of immunoglobulins. Scand J Clin Lab Invest 41(Suppl 157):1–84.Google Scholar
  240. 240.
    Statz A, Felgenhauer K (1983). Development of the blood-CSF barrier. Dev Med Child Neurol 25:152–161.PubMedGoogle Scholar
  241. 241.
    Staugaitis SM, Myers L, Ellison G, Tourtellotte WW, Shapshak P (1984). Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone. Neurology 34:228.Google Scholar
  242. 242.
    Stendahl-Brodin L, Link H (1980). Relation between the benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 43:102–105.PubMedGoogle Scholar
  243. 243.
    Standahl-Brodin L, Link H (1983). Optic neuritis: Oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol Scand 67:301–304.Google Scholar
  244. 244.
    Strony LP, Wagner K, Keshgegian AA (1982). Demonstration of cerebrospinal fluid oligoclonal banding in neurologic diseases by agarose gel electrophoresis and immunofixation. Clin Chim Acta 122:203–212.PubMedGoogle Scholar
  245. 245.
    Tachovsky TG, Sandberg-Wollheim M, Baird LG (1982). Rabbit anti-human CSF IgG. J Immunol 129:764–770.PubMedGoogle Scholar
  246. 246.
    Takeoka T, Gotoh F, Furumi K, Mori K (1976). Polyacrylamide-gel disc electrophoresis of native cerebrospinal fluid proteins with special reference to immunoglobulins and some clinical applications. J Neurol Sci 29:213–329.PubMedGoogle Scholar
  247. 247.
    Takeoka T, Shinohara Y, Furumi K, Mori K (1983). Impairment of blood-cerebrospinal fluid barrier in multiple sclerosis. J Neurochem 41:1102–1108.PubMedGoogle Scholar
  248. 248.
    Terasaki PI, Mottironi VD, Barnett EV (1970). Cytotoxins in disease—autocytotoxins in lupus. N Engl J Med 283:724–728.PubMedGoogle Scholar
  249. 249.
    Thompson EJ, Luxon LM, Jethwa J, Chortman RC, Paul E (1982). On the relationship of CSF pleocytosis to immunoglobulin levels as estimated by different techniques. J Neuro-immunol 2:321–330.Google Scholar
  250. 250.
    Thompson EJ, Kaufmann P, Rudge P (1983). Sequential changes in oligoclonal patterns during the course of multiple sclerosis. J Neurol Neurosurg Psychiatry 46:547–550.PubMedGoogle Scholar
  251. 251.
    Thomson D, Connolly JH, Underwood BP, Brown F (1974). A study of immunoglobulin M antibody to measles, canine distemper and Rinderpest viruses in sera of patients with subacute sclerosing panencephalitis. Med Microbiol Immunol 160:209.Google Scholar
  252. 252.
    Thorsby E, Helgesen A, Solheim BG, Vandvik B (1977). HLA antigens in multiple scleYrosis. J Neurol Sci 32:187–193.PubMedGoogle Scholar
  253. 253.
    Tibbling G, Link H, Ohman S (1977). Principles of albumin and IgG analyses in neuroYlogical disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37:385–390.PubMedGoogle Scholar
  254. 254.
    Tourtellotte WW (1970). On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. J Neurol Sci 10:279–304.PubMedGoogle Scholar
  255. 255.
    Tourtellotte WW (1971). Cerebrospinal fluid immunoglobulins and the central nervous system as an immunological organ particularly in multiple sclerosis and subacute sclerosYing panencephalitis. In: LP Rowland (ed.): Association for Research in Nervous and Mental Diseases: Immunological Disorders of the Nervous System. Volume 49. Baltimore: Williams and Wilkins, pp. 112–155.Google Scholar
  256. 256.
    Tourtellotte WW, Tavolato B, Parker JA , Comiso P (1971). Cerebrospinal fluid elec-troimmunodiffusion. Arch Neurol 25:345–350.PubMedGoogle Scholar
  257. 257.
    Tourtellotte WW, Ma BI (1978). Multiple sclerosis: The blood-brain barrier and the meaYsurement of de novo central nervous system IgG synthesis. Neurology 28:76–83.PubMedGoogle Scholar
  258. 258.
    Tourtellotte WW, Baumhefner RW, Potvin AR, Ma BI, Potvin JH, Mendez M, Syndulko K (1980). Multiple sclerosis de novo CNS IgG synthesis: Effect of ACTH and corticosteroids. Neurology 30:1155–1162.PubMedGoogle Scholar
  259. 259.
    Tourtellotte WW, Potvin AR, Baumhefner RW, Potvin JH, Ma BI, Syndulko K, Petrovich Z (1980). Multiple sclerosis de novo CNS IgG synthesis effect of CNS irradiation. Arch Neurol 37:620–624.PubMedGoogle Scholar
  260. 260.
    Tourtellotte WW, Potvin AR, Fleming JO, Murthy KN, Levy J, Syndulko K, Potvin JH (1980). Multiple sclerosis: Measurement and validation of central nervous system IgG synthesis rate. Neurology 30:240–244.PubMedGoogle Scholar
  261. 261.
    Tourtellotte WW, Ma BI, Brandes DB, Walsh MJ, Potvin AR (1981). Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE. Ann Neurol 9: 551–556.PubMedGoogle Scholar
  262. 262.
    Tourtellotte WW, Staugaitis SM, Walsh MJ, Shapshak P, Baumhefner RW, Potvin AR, Syndulko K (1985). The basis of intra-blood-brain-barrier IgG synthesis. Ann Neurol 17:21–27.PubMedGoogle Scholar
  263. 263.
    Tourtellotte WW, Shapshak P, Ellison GW, Myers LW, Lee MM (1985). Intensive and chronic cyclophosphamide administration to patients with multiple sclerosis had no major effect on intra-blood-brain-barrier IgG synthesis. Ann Neurol 18:13–1.Google Scholar
  264. 264.
    Traugott U, Reinherz EL, Raine CS (1983). Multiple sclerosis—Distribution of T cells, T cell subsets, and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 4: 201–221.PubMedGoogle Scholar
  265. 265.
    Trotter JL, Brooks BR (1980). Pathophysiology of cerebrospinal fluid immunoglobulins. In: Wood JH (ed.): Neurobiology of Cerebrospinal Fluid. Volume 1. New York: Plenum, pp. 465–486.Google Scholar
  266. 266.
    Trotter JL, Garvey WF (1980). Prolonged effects of large-dose methylprednisolone infusion in multiple sclerosis. Neurology 30:702–708.PubMedGoogle Scholar
  267. 267.
    Vakaet A, Thompson EJ (1985). Free light chains in the cerebrospinal fluid—an indicator of recent immunological stimulation? J Neurol Neurosurg Psychiatry 48:945–948.Google Scholar
  268. 268.
    Valenzuela R, Mandler R, Goren H (1982). Immunonephelometric quantitation of central nervous system IgG daily synthesis in multiple sclerosis. Amer J Clin Path 78:22–28.Google Scholar
  269. 269.
    Vandvik B, Norrby E (1973). Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Nat Acad Sci USA 4:1060–1063.Google Scholar
  270. 270.
    Vandvik V, Norrby E, Nordal HJ, Degré M (1976). Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol 5:979–992.PubMedGoogle Scholar
  271. 271.
    Vandvik B (1977). Oligoclonal IgG and free light chains in the cerebrospinal fluid of patients with multiple sclerosis and infectious diseases of the central nervous system. Scand J Immunol 6:913–922.PubMedGoogle Scholar
  272. 272.
    Vandvik B (1977) Oligoclonal measles virus-specific IgG antibodies isolated from sera of patients with subacute sclerosing panencephalitis. Scand J Immunol 6:641–649.PubMedGoogle Scholar
  273. 273.
    Vartdal F, Vandvik B, Norrby E (1980). Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 8:248–255.PubMedGoogle Scholar
  274. 274.
    Vartdal F, Vandvik B (1982). Multiple sclerosis: Electrofocused “bands” of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses. J Neurol Sci 54:99–107.PubMedGoogle Scholar
  275. 275.
    Vartdal F, Vandvik B, Michaelsen TE, Loe K, Norrby E (1982). Neurosyphilis: Intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol 11:35–40.PubMedGoogle Scholar
  276. 276.
    Vartdal F, Vandvik B (1983). Multiple sclerosis: Subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies. Clin Exp Immunol 54:641–647.PubMedGoogle Scholar
  277. 277.
    Verjans E, Theys P, Delmotte P, Carton H (1983). Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. J Neurol 229:155–165.PubMedGoogle Scholar
  278. 278.
    Voulters L, Ebers GC (1984). Agarose isoelectric focusing of CSF. Neurology 34:227.Google Scholar
  279. 279.
    Walker RWH, Keir G, Johnson MH, Thompson EJ (1983). A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol 4:141–148.PubMedGoogle Scholar
  280. 280.
    Walsh MJ, Staugaitis S, Shapshak P, Tourtellotte WW (1982). Ultrasensitive detection of IgG in unconcentrated cerebrospinal fluid utilizing silver nitrate straining after isoelectric focusing and immunofixation. Ann Neurol 12:114.Google Scholar
  281. 281.
    Walsh MJ, Tourtellotte WW, Potvin AR, Potvin JH (1983). The cerebrospinal fluid in multiple sclerosis. In: Hallpike JF, Adams CWM, Tourtellotte WW (eds.): Multiple Sclerosis: Pathology, Diagnosis and Management. Baltimore: Williams and Wilkins, pp. 275–358.Google Scholar
  282. 282.
    Walsh MJ, Tourtellotte WW, Roman J, Dreyer W (1985). Immunoglobulin G, A, and Mclonal restriction in multiple sclerosis cerebrospinal fluid and serum-analysis by two-dimensional electrophoresis. Clin Immunol Immunopath 35:313–327.Google Scholar
  283. 283.
    Walsh MJ, Tourtellotte WW (1986). Temporal invariance and clonal uniformity of brain and cerebrospinal IgG. IgA, and IgM in multiple sclerosis. J Exp Med 163:41–53.PubMedGoogle Scholar
  284. 284.
    Warren KG, Catz I (1986). Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis. Ann Neurol 20:20–25.PubMedGoogle Scholar
  285. 285.
    Weiner HL, Schocket AL (1979). Lymphocytes in multiple sclerosis: Correlation with CSF immunoglobulins and cold-reactive lymphocytotoxic antibodies. Neurology 29:1504–1508.PubMedGoogle Scholar
  286. 286.
    Whitaker JN (1985). Quantitation of the synthesis of immunoglobulin G within the central nervous system. Ann Neurol 17:11.PubMedGoogle Scholar
  287. 287.
    Wikkelso C, Andersson M, Andersson R, Blomstrand C (1984). Isoelectric focusing followed by silver staining. Eur Neurol 23:306–312.PubMedGoogle Scholar
  288. 288.
    Williams A, Papadopoulos N, Chase TN (1980). Demonstration of CSF gamma-globulin banding in presenile dementia. Neurology 30:882–884.PubMedGoogle Scholar
  289. 289.
    Xu XH, McFarlin DE (1984). Oligoclonal bands in CSF: Twins with MS. Neurology 34: 769–774.PubMedGoogle Scholar
  290. 290.
    Yahr MD, Goldensohn SS, Kabat EA (1954). Further studies on the gamma globulin content of cerebrospinal fluid in multiple sclerosis and other neurological diseases. Ann NY Acad Sci 58:613–624.Google Scholar
  291. 291.
    Yahr MD, Kabat EA (1957). Cerebrospinal fluid and serum gamma globulin levels in multiple sclerosis: Changes induced by large doses of prednisone. Trans Am Neurol Assoc 92:115–119.Google Scholar
  292. 292.
    Zettervall O, Link H (1970). Electrophoretic distribution of kappa and lambda immunoglobulin light chain determinants in serum and cerebrospinal fluid in multiple sclerosis. Clin Exp Immunol 7:365–372.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • John L. Trotter
  • Robert S. Rust

There are no affiliations available

Personalised recommendations